Financial Performance: Luokung Technologies has reported strong revenue growth over the past few years, driven by its increasing number of customers and growing demand for its services.

Based on the above factors, it is possible to assign a fair value to Luokung Technologies.

Bullish on the idea of the technology

$LKCO Someone tell David Michery AKA $MULN about Luokung technology $LKCO I’m sure he will jump in to buy this as part of his product and service portfolio at such a cheap price 😄!

Property and technology stocks continued to rally, leading the Hang Seng index.

- Yitutong has developed smart refueling technology that allows vehicles to automatically refuel at L3-L5 levels, and its high-precision maps are used to provide traffic and location services to improve vehicle-road coordination.

$LKCO when it comes to technology Chinese are supposed to be fairly intelligent😂 so if that holds true can we say we are in good hands🙏🤣

The confidence is we believe in this technology and it’s fundamentals !

(CEO Song has 38 Million shares) I trust his Greed and good Luokung Technology until something better to believe.

$LKCO Powerhouse of technologies through smart acquisitions !!!

Heartbeat technology is far ahead of its competition!

This technology is truly game changing and when approved production will respond quickly.

$beat has technology and products that may save many, many lives.

but I do feel the area of medical technology and healthcare provide for good investment opportunity.

Currently I am very Bullish on $ivda and $beat that I believe both have Technology and or AI that could be disruptive and hugely profitable to investors.

$BEAT technology is great at Diagnosing Heart Attack during hump day.

$SOBR this is groundbreaking technology.

Game changing technology.

Here is a company that will save huge amount of lives with new/updated technology and has a market cap of 32 million!!!!!

"We were pleased by the progress our team has made over the past quarter, highlighted by our decision to expand the addressable patient population for our HeartBeam AIMI platform technology by including unstable angina as a diagnosis for analysis.